SCHEMBL981539

SCHEMBL981539

c1ccc(N(c2cccc3ccccc23)c2c3ccccc3c(-c3c4ccccc4c(N(c4ccccc4)c4cccc5ccccc45)c4ccccc34)c3ccccc23)cc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 9/20 0.44
L3MBTL1 Q9Y468 1/20 0.36
CYP1A2 P05177 3/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
ALDH1A1 P00352 4/20 0.33
CYP2A6 P11509 3/20 0.33
TSHR P16473 2/20 0.33
HSD17B10 Q99714 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
NR4A1 P22736 1/20 0.32
NR4A2 P43354 1/20 0.32
NR4A3 Q92570 1/20 0.32
HPGD P15428 1/20 0.32
KEAP1 Q14145 1/20 0.32
KDM4E B2RXH2 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30205806 1.00 SIGMAR1 (0.44) SIGMAR1L3MBTL1CYP1A2CYP3A4CYP2D6
SCHEMBL4650694 0.94 SIGMAR1 (0.47) SIGMAR1L3MBTL1CYP1A2CYP3A4CYP2D6
SCHEMBL13899982 0.94 SIGMAR1 (0.40) SIGMAR1L3MBTL1CYP1A2CYP3A4CYP2D6
SCHEMBL13250570 0.93 SIGMAR1 (0.46) SIGMAR1L3MBTL1CYP1A2CYP3A4CYP2D6
SCHEMBL4921270 0.91 SIGMAR1 (0.45) SIGMAR1L3MBTL1CYP1A2CYP3A4CYP2D6
SCHEMBL14461155 0.90 SIGMAR1 (0.40) SIGMAR1L3MBTL1CYP1A2CYP3A4CYP2D6
SCHEMBL2332208 0.88 SIGMAR1 (0.43) SIGMAR1L3MBTL1CYP1A2CYP3A4CYP2D6
SCHEMBL4894433 0.87 SIGMAR1 (0.44) SIGMAR1L3MBTL1CYP1A2CYP3A4CYP2D6
SCHEMBL22671610 0.87 SIGMAR1 (0.40) SIGMAR1L3MBTL1CYP1A2CYP3A4CYP2D6
SCHEMBL20930952 0.87 SIGMAR1 (0.40) SIGMAR1L3MBTL1CYP1A2ALDH1A1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 147 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4592297-A1 AN ORGANIC BORON COMPOUND, AN ORGANIC LIGHT EMITTING DIODE COMPRISING THE ORGANIC BORON COMPOUND, A USE OF THE DIODE, AND A CONSUMER PRODUCT Noctiluca S.A. (PL) 2025-07-30 EP claimed
US-8507896-B2 Compounds having electroluminescent or electron transport properties MERCK PATENT GMBH (DE) 2013-08-13 US claimed
EP-2286474-A2 METHOD OF MAKING AN OLED Merck Patent GmbH (DE) 2011-02-23 EP claimed
US-20110006295-A1 COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES MERCK PATENT GMBH 2011-01-13 US claimed
WO-2009149860-A2 METHOD OF MAKING AN OLED MERCK PATENT GMBH (DE) 2009-12-17 WO claimed
US-20260007026-A1 Display Panel and Display Apparatus CHENGDU BOE OPTOELECT TECH CO (CN) 2026-01-01 US disclosed
US-12480040-B2 Display substrate and display apparatus Beijing Boe Technology Development Co., Ltd. (CN) 2025-11-25 US disclosed
EP-4592297-A1 AN ORGANIC BORON COMPOUND, AN ORGANIC LIGHT EMITTING DIODE COMPRISING THE ORGANIC BORON COMPOUND, A USE OF THE DIODE, AND A CONSUMER PRODUCT Noctiluca S.A. (PL) 2025-07-30 EP disclosed
US-11873293-B2 Organic molecules for optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2024-01-16 US disclosed
US-11873293-B2 Organic molecules for optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2024-01-16 US disclosed
US-20230354693-A1 SUPERFLUORESCENT CERIUM (III)-CONTAINING CHELATE APPLICABLE TO PHOTOELECTRIC DEVICES AND HAVING A DUAL CAPTURE MECHANISM AND ULTRA-SHORT DECAY TIME SICHUAN KNOWLEDGE EXPRESS INSTITUTE FOR INNOVATIVE TECHNOLOGIES CO., LTD (CN) 2023-11-02 US disclosed
US-20230337538-A1 ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2023-10-19 US disclosed
WO-2008078114-A1 ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2008-07-03 WO disclosed
US-20080138654-A1 Electroluminescent Materials and Devices OLED-T LIMTED (GB) 2008-06-12 US disclosed
US-20080138654-A1 Electroluminescent Materials and Devices OLED-T LIMTED (GB) 2008-06-12 US disclosed
US-20080113215-A1 Electroluminescent Materials and Devices MERCK PATENT GMBH (DE) 2008-05-15 US disclosed
US-20080113215-A1 Electroluminescent Materials and Devices MERCK PATENT GMBH (DE) 2008-05-15 US disclosed
WO-2008012581-A2 CATHODE COATING MERCK PATENT GMBH (DE) 2008-01-31 WO disclosed
US-20070259208-A1 Electroluminescent materials and devices MERCK PATENT GMBH (DE) 2007-11-08 US disclosed
US-20070200096-A1 Doped lithium quinolate OLED-T LIMITED (GB) 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337538-A1 ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES OCIAD1, OCIAD2, OR10J3 SIGMAR1 837/4885L3MBTL1 938/4885CYP1A2 2716/4885
US-20260007026-A1 Display Panel and Display Apparatus CD79B, CD22, LBR SIGMAR1 1098/4885L3MBTL1 315/4885CYP1A2 3326/4885
US-20110006295-A1 COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES NR2E3, NR4A2, NR4A3 SIGMAR1 438/4885L3MBTL1 2419/4885CYP1A2 544/4885
US-11873293-B2 Organic molecules for optoelectronic devices XDH, C1S, OR10J3 SIGMAR1 1014/4885L3MBTL1 3200/4885CYP1A2 1532/4885
US-20230354693-A1 SUPERFLUORESCENT CERIUM (III)-CONTAINING CHELATE APPLICABLE TO PHOTOELECTRIC DEVICES AND HAVING A DUAL CAPTURE MECHANISM AND ULTRA-SHORT DECAY TIME OCIAD2, OCIAD1, CASR SIGMAR1 59/4885L3MBTL1 3157/4885CYP1A2 3869/4885
US-20080113215-A1 Electroluminescent Materials and Devices AAAS, ACMSD, KCNH1 SIGMAR1 4264/4885L3MBTL1 2486/4885CYP1A2 1148/4885
US-20080138654-A1 Electroluminescent Materials and Devices DDT, SLC18A2, SAT1 SIGMAR1 2367/4885L3MBTL1 2703/4885CYP1A2 3610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.